| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00404096 |
| P698 | PubMed publication ID | 2401399 |
| P2093 | author name string | W C Knowler | |
| R G Nelson | |||
| D J Pettitt | |||
| P H Bennett | |||
| M F Saad | |||
| P2860 | cites work | Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota | Q34057383 |
| Raised arterial pressure in parents of proteinuric insulin dependent diabetics. | Q34071672 | ||
| The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival | Q34312880 | ||
| Use of single voided urine samples to estimate quantitative proteinuria | Q34662083 | ||
| Protein creatinine index and Albustix in assessment of proteinuria | Q34995082 | ||
| The changing natural history of nephropathy in type I diabetes | Q38520789 | ||
| Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians | Q39622035 | ||
| The genetics of diabetic complications | Q39748092 | ||
| Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? | Q40215239 | ||
| Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy | Q41306582 | ||
| Diabetic nephropathy: an hypothesis regarding genetic susceptibility for the disorder | Q41474595 | ||
| Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition | Q42037196 | ||
| Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study | Q50584833 | ||
| A clinical and histologic study of diabetic nephropathy in the Pima Indians. | Q53731293 | ||
| Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. | Q54136807 | ||
| Effect of proteinuria on mortality in NIDDM | Q67954056 | ||
| Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria | Q68582537 | ||
| Systemic hypertension, diabetes mellitus and the kidney | Q69461373 | ||
| Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians | Q69737779 | ||
| What causes diabetic renal failure? | Q69919979 | ||
| Covariance adjustment of rates based on the multiple logistic regression model | Q70875975 | ||
| A detailed study of risk factors for retinopathy and nephropathy in diabetes | Q71211276 | ||
| Early onset of clinical diabetic nephropathy in children--a new subgroup? | Q71326680 | ||
| Predicting diabetic nephropathy in insulin-dependent patients | Q71401816 | ||
| Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion | Q71622424 | ||
| Mortality from diabetic nephropathy in the United Kingdom | Q71825418 | ||
| Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus | Q72528281 | ||
| Diabetes mellitus in American (Pima) Indians | Q93704220 | ||
| P433 | issue | 7 | |
| P921 | main subject | Akimel O'odham | Q209148 |
| kidney disease | Q1054718 | ||
| P304 | page(s) | 438-443 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus | |
| P478 | volume | 33 |
| Q43857799 | (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus |
| Q42378585 | 6. Diabetic Nephropathy |
| Q52804042 | A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. |
| Q33783045 | A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy |
| Q60300866 | A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes |
| Q38317953 | ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information |
| Q47217404 | Adult height and proteinuria in type 2 diabetes |
| Q51025301 | Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. |
| Q35105891 | Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients |
| Q30349890 | An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. |
| Q43771066 | Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients |
| Q73235838 | Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes |
| Q36981692 | Applying novel genome-wide linkage strategies to search for loci influencing type 2 diabetes and adult height in American Samoa |
| Q70989583 | Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics |
| Q33869853 | Association between CNDP1 genotype and diabetic nephropathy is sex specific. |
| Q72318357 | Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group |
| Q35004388 | Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians |
| Q64936514 | Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus. |
| Q79215905 | C-106T polymorphism of AKR1B1 is associated with diabetic nephropathy and erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes mellitus |
| Q34215763 | CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients |
| Q41527666 | Can we further slow down the progression to end-stage renal disease in diabetic hypertensive patients? |
| Q79365881 | Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy |
| Q33950267 | Co-occurrence of diabetes and hypertension: pattern and factors associated with order of diagnosis among nigerians |
| Q41123351 | Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. |
| Q37101559 | Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection |
| Q92462758 | Comparison of renal arterial resistive index in type 2 diabetic nephropathy stage 0-4 |
| Q73200151 | Contribution of HLA class II genes to end stage renal disease in mexican patients with type 2 diabetes mellitus |
| Q37365616 | Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group |
| Q59150879 | Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria |
| Q33836508 | Diabetes in the elderly population. |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q74764027 | Diabetic nephropathy |
| Q59220162 | Diabetic nephropathy |
| Q34387952 | Diabetic nephropathy - complications and treatment |
| Q41003506 | Diabetic nephropathy in type II diabetes |
| Q35977682 | Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. |
| Q41563034 | Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention |
| Q56438574 | Diabetic nephropathy: a risk factor for diabetes mellitus in offspring |
| Q37262935 | Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype |
| Q59150371 | ELMO1 variants and susceptibility to diabetic nephropathy in American Indians |
| Q30410401 | Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products |
| Q54104998 | Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. |
| Q37689847 | Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients. |
| Q38105995 | Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy |
| Q44203119 | Endothelial nitric oxide synthase gene and the development of diabetic nephropathy |
| Q41107195 | Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs |
| Q74451553 | Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients |
| Q35606664 | Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians |
| Q83943932 | Factors associated with diabetic nephropathy in subjects with proliferative retinopathy |
| Q67745344 | Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy |
| Q77883730 | Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India |
| Q43532820 | Familial clustering of end-stage renal disease in blacks with lupus nephritis |
| Q33883432 | Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy |
| Q35106796 | Genetic aspects of diabetic nephropathy |
| Q38152958 | Genetic associations in diabetic nephropathy. |
| Q34153165 | Genetic associations in diabetic nephropathy: a meta-analysis |
| Q46840744 | Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans |
| Q51920914 | Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. |
| Q35087451 | Genetics of diabetes complications |
| Q94600785 | Genetics of diabetes mellitus and diabetes complications |
| Q35087689 | Genetics of diabetic nephropathy in the Pima Indians |
| Q79190007 | Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q |
| Q36785588 | Histopathology of diabetic nephropathy |
| Q47612824 | Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? |
| Q85193202 | Identification of Novel Genetic Markers and Improved Treatment Options for Diabetic Kidney Disease |
| Q44435407 | In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy |
| Q57944143 | Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects |
| Q79144670 | Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians |
| Q33727855 | Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice |
| Q26823352 | Insights into the genetic architecture of diabetic nephropathy |
| Q83377325 | Insulin resistance and the metabolic syndrome in obese French children |
| Q91671449 | Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population |
| Q71482769 | Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus |
| Q61905689 | Intracellular calcium handling by fibroblasts from non-insulin dependent diabetic patients with and without hypertension and microalbuminuria |
| Q35725051 | Kidney disease and youth onset type 2 diabetes: considerations for the general practitioner |
| Q58210012 | Lack of association of angiotensin-converting enzyme (Dd/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes |
| Q47670854 | Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients |
| Q36911146 | Natural history and pathogenesis of diabetic nephropathy |
| Q36911152 | Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus |
| Q50955890 | Nephropathy of type II diabetes: evidence for hereditary factors? |
| Q37598306 | New insights into molecular mechanisms of diabetic kidney disease |
| Q41690327 | Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy |
| Q51013864 | Parental hypertension and proteinuria in Pima Indians with NIDDM. |
| Q81066721 | Pathogenesis of diabetic nephropathy |
| Q45150525 | Peroxisome proliferator-activated receptor gamma gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients. |
| Q82945501 | Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease |
| Q24658206 | Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients |
| Q46509027 | Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitu |
| Q61905678 | Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate |
| Q48561405 | Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. |
| Q41431049 | Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy |
| Q46864778 | Racial variation in autosomal dominant polycystic kidney disease |
| Q34707878 | Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan |
| Q73373298 | Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy |
| Q34215822 | Renal function and renal disease in the elderly: Part I. |
| Q40781800 | Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients--a review |
| Q41431044 | Renal mortality associated with non-insulin-dependent diabetes mellitus |
| Q41107223 | Renal syndromes in diabetes |
| Q35087673 | Risk predictors in patients with diabetic nephropathy |
| Q33183125 | Role of ACE inhibitors in patients with diabetes mellitus |
| Q40743718 | Structural-functional correlations of diabetic nephropathy |
| Q36293641 | TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese |
| Q64121353 | The Familiality of Rapid Renal Decline in Diabetes |
| Q36515022 | The genetic risk of kidney disease in type 2 diabetes |
| Q38396875 | The genetics of diabetic complications |
| Q73303194 | The heparan sulfate proteoglycan gene polymorphism: association with type 2 diabetic nephropathy in Chinese |
| Q42124266 | The number of glomeruli in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients |
| Q37209550 | The pathogenesis of diabetic nephropathy |
| Q35087523 | The relationship between glucose control and the development and progression of diabetic nephropathy |
| Q45960404 | The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy. |
| Q54373570 | The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. |
| Q57378000 | U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM |
Search more.